CONNECT WITH US
AI & Deeptech

AI & Deeptech

Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and development

IndiaTimes (ET) - AI logo

Published on

Add as a preferred source on Google
Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and development

Business News Tech AI Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and development

Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and development

The Ministry of Science has entered into a partnership with Peptris Technologies to bolster drug development under the initiative called VIGOR. This venture, which possesses a total estimated budget of Rs 172 crore, aims to leverage artificial intelligence to refine four experimental drugs targeting critical health issues like neuromuscular disorders and diabetes.

The Ministry of Science 's Technology Development Board (TDB) has signed an agreement with Bengaluru-based Peptris Technologies Pvt Ltd for financial support of Rs 86 crore to accelerate the development of next-generation therapies through Artificial Intelligence (AI), it said on Monday. According to an official statement, the project called 'VIGOR--Moving AI-Discovered Molecules from the Lab to the Clinic' has a total cost of Rs 172 crore. The aim is to advance four experimental drugs to technology readiness levels (TRLs) 4 to 6, requiring preclinical development, validation, and preparation for clinical trials. Financial support will be provided through optionally convertible debt (OCD). "The application of artificial intelligence in pharmaceutical research has the potential to transform the way new drugs are identified and developed. However, converting promising discoveries into proven therapeutics requires sustained investment, rigorous scientific evaluation, and a structured development process," Rajesh Kumar Pathak, TDB Secretary, said in the statement.

"Through the RDI Fund, TDB is supporting such technology-intensive programs to bridge the gap between innovation and clinical development, as well as strengthen India's capabilities in biotechnology, pharmaceuticals and AI-based healthcare innovation," he added.


Source link
Related Topics:AI & Deeptech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.